PA
DRTSW icon

Parallel Advisors’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Parallel Advisors’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,600
Closed -$1.08K – 3327
2023
Q4 		$1.08K Hold
5,600
– – ﹤0.01% 2918
2023
Q3 		$1.42K Hold
5,600
– – ﹤0.01% 2903
2023
Q2 		$2.21K Buy
+5,600
New +$1.71K ﹤0.01% 2727

Other funds holding DRTSW

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Parallel Advisors's DRTSW Position: Q1 2024 in Review

Parallel Advisors sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2024, closing a stake of 5,600 shares — an estimated $1.08K sold.

Parallel Advisors first reported a position in DRTSW in Q2 2023 and held it in 3 quarters. The position peaked at $2.21K in Q2 2023. 27 funds tracked by Wall St. Rank hold DRTSW as of Q1 2024.

  • Parallel Advisors reported no remaining Alpha Tau Medical Warrant position as of Q1 2024 after selling out during the quarter.
  • Parallel Advisors sold 5,600 Alpha Tau Medical Warrant shares in Q1 2024, an estimated $1.08K.
  • Parallel Advisors first reported a position in Alpha Tau Medical Warrant in Q2 2023 and held it in 3 quarters.
  • Parallel Advisors's Alpha Tau Medical Warrant position peaked at $2.21K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.